Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>FY09/24 sales were JPY14.9bn (+2.8% YoY), with operating profit at JPY1.3bn (+15.3% YoY), exceeding forecasts.</li><li>The Preventative Healthcare Platform exited, transferring operations to subsidiaries of Advantage Risk Management, effective September 30, 2024.</li><li>FY09/25 forecast predicts sales of JPY12.4bn (-17.0% YoY) and net income of JPY500mn (-66.3% YoY).</li></ul>

FY09/24 sales were JPY14.9bn (+2.8% YoY), with operating profit at JPY1.3bn (+15.3% YoY), exceeding forecasts.The Preventative Healthcare Platform exited, transferring operations to subsidiaries of Advantage Risk Management, effective September 30, 2024.FY09/25 forecast predicts sales of JPY12.4bn (-17.0% YoY) and net income of JPY500mn (-66.3% YoY).

Medpeer Inc (6095 JP): Full-year FY09/24 flash update 

<ul><li>Sales were JPY11.4bn (+7.1% YoY), EBITDA JPY1.5bn (+10.3% YoY), operating profit JPY1.0bn (+24.7% YoY), net income JPY429mn (+5.0% YoY).</li><li>Revised FY09/24 forecast: Sales JPY14.6bn, EBITDA JPY1.8bn, operating profit JPY1.2bn, recurring profit JPY1.1bn, net income JPY1.4bn.</li><li>Segment performance: Collective Intelligence Platform sales JPY9.3bn (+8.5% YoY), Medical Institution Support sales JPY377mn (+2.6% YoY), Preventative Healthcare sales JPY1.7bn (+1.4% YoY).</li></ul>

Sales were JPY11.4bn (+7.1% YoY), EBITDA JPY1.5bn (+10.3% YoY), operating profit JPY1.0bn (+24.7% YoY), net income JPY429mn (+5.0% YoY).Revised FY09/24 forecast: Sales JPY14.6bn, EBITDA JPY1.8bn, operating profit JPY1.2bn, recurring profit JPY1.1bn, net income JPY1.4bn.Segment performance: Collective Intelligence Platform sales JPY9.3bn (+8.5% YoY), Medical Institution Support sales JPY377mn (+2.6% YoY), Preventative Healthcare sales JPY1.7bn (+1.4% YoY).

Medpeer Inc (6095 JP): Q3 FY09/24 Flash Update, Revision of Full-Year FY09/24 Earnings Forecast

Japan

MEDPPEER provide social network services for the medical/pharmaceutical professionals. The service is intended to share knowledge, analysis, and treatment results to improve their medical practice.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medpeer Inc (6095 JP)